Archives

by in
Entry Author Date Location
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery 01/21/10 National
Ambit Signs Big Deal With Astellas, Xenomics Alleges Fraud at Sequenom, Arena Seeks FDA Approval for Weight-Loss Drug & More San Diego Life Sciences News 12/24/09 San Diego
Regulus Adds IP from Baltimore Lab 12/17/09 San Diego
Xconomy Forum: The Biotech Odyssey and Xconomy’s Ode to Innovation and Clean Air 12/15/09 San Diego
Nobel Laureate from Caltech, RNAi Leader To Headline Xconomy San Diego Event on Monday 12/09/09 San Diego
San Diego Biotech Leaders on the Future of Stem Cells, MicroRNA, & Cancer Biology 12/01/09 San Diego
Who Will Create the Future of San Diego Biotech? Xconomy Event Will Gather Star Innovators From Inside and Outside the Region 11/10/09 San Diego
Epizyme Grabs $32M, A123 Systems’ IPO Enriches BU, & More Boston-Area Deals News 10/12/09 Boston
Alnylam Chief Foresees Another Gene-Silencing Spin-Off, and More News Tidbits from Boston’s MassBio Investors Forum 10/07/09 Boston
MicroRNA Drug Developer Santaris Establishes Toehold in San Diego With Isis Veteran 09/16/09 San Diego
$50M for Helicon, Cytori Bulks Up, Avanir Awaits Trial Results, & More San Diego Life Sciences News 07/30/09 San Diego
Alnylam and Isis’ Offspring, Regulus, Keeps Pushing on Biology’s ‘Bleeding Edge’ 07/28/09 San Diego
Regulus Hits GSK Milestone 05/14/09 San Diego
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers 04/29/09 San Diego
ImmunoGen Drug Nears Finish Line, Surface Logix Latches Onto $20M, Athenahealth CEO Bush Talks Stimulus, & More Boston-Area Life Sciences News 03/11/09 Boston
Vertex Puts up $375M for ViroChem, Nuance Finally Nabs Zi, Proteon Procures $38M, & More Boston-Area Deals News 03/06/09 Boston
Regulus Therapeutics Follows Through on Fundraising, Independence Plans 03/04/09 San Diego
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News 02/25/09 Boston
Alnylam Looks to Spinoffs To Unleash RNAi Technologies for Stem Cells, Vaccines 02/18/09 Boston
Regulus Strikes Out On Its Own, J&J Seeks “Enlight”-enment, Synta Awaits Melanoma Data, & More Boston-Area Life Sciences News 01/28/09 Boston
Pfizer-Wyeth Combo’s Impact on San Diego Biotech: Bad for Dealmaking, Good for Shareholders 01/27/09 San Diego
Qualcomm Buys Multimedia Technology, SD Consortium Advances Biofuels Initiative, Biotech VCs Adapt, & More San Diego BizTech News 01/26/09 San Diego
Regulus, Leading Developer of MicroRNA Drugs, Prepares to Get Independence from Alnylam and Isis 01/21/09 San Diego
Alnylam Shoots for the Moon in 2009, Predicts Two More Deals To Come 01/12/09 Boston
MicroRNA Leaps Ahead: Alnylam-Isis Venture, Regulus, Shows Its Drug Works in Animals With Heart Failure 11/30/08 San Diego
Biotech Survival Index: Cash Woes Creeping Up on San Diego Life Sciences Companies 11/18/08 San Diego
Sirtris Shifts Focus From Resveratrol, Merck Shifts People From Seattle to Boston, Epix Shifts Into Cost-Saving Mode, & More Boston-Area Life Sciences News 10/29/08 Boston
Accelerator Bankrolls New Company, Mirina, To Develop MicroRNA-Blocking Drugs 08/15/08 Seattle
Alnylam’s In the Money: Expects $500 Million in Bank at Year-End 08/06/08 Boston
Mass Biotech Council’s Image Troubles, Boston Scientific’s Mixed Bag, Another Big IPO in the Offing, and More 09/10/07 Boston
Page 2 of 2 « previous page